Operating Expenses - Hofseth Biocare ASA (OSE:HBC) - Alpha Spread

Hofseth Biocare ASA
OSE:HBC

Watchlist Manager
Hofseth Biocare ASA Logo
Hofseth Biocare ASA
OSE:HBC
Watchlist
Price: 1.705 NOK -4.21% Market Closed
Market Cap: 610.1m NOK
Have any thoughts about
Hofseth Biocare ASA?
Write Note

Hofseth Biocare ASA
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hofseth Biocare ASA
Operating Expenses Peer Comparison

Comparables:
B
BGBIO
L
LYTIX
AZT
N
NYKD
T
TRMED

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Hofseth Biocare ASA
OSE:HBC
Operating Expenses
-kr180.7m
CAGR 3-Years
-12%
CAGR 5-Years
-15%
CAGR 10-Years
-8%
B
Bergenbio ASA
OSE:BGBIO
Operating Expenses
-kr159.7m
CAGR 3-Years
18%
CAGR 5-Years
4%
CAGR 10-Years
N/A
L
Lytix Biopharma AS
OSE:LYTIX
Operating Expenses
-kr100.8m
CAGR 3-Years
-33%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
Arcticzymes Technologies ASA
OSE:AZT
Operating Expenses
-kr100.4m
CAGR 3-Years
-23%
CAGR 5-Years
-10%
CAGR 10-Years
-9%
N
Nykode Therapeutics ASA
OSE:NYKD
Operating Expenses
-$69.6m
CAGR 3-Years
-20%
CAGR 5-Years
-62%
CAGR 10-Years
N/A
T
Thor Medical ASA
OSE:TRMED
Operating Expenses
-kr35.8m
CAGR 3-Years
56%
CAGR 5-Years
36%
CAGR 10-Years
-7%

See Also

What is Hofseth Biocare ASA's Operating Expenses?
Operating Expenses
-180.7m NOK

Based on the financial report for Mar 31, 2024, Hofseth Biocare ASA's Operating Expenses amounts to -180.7m NOK.

What is Hofseth Biocare ASA's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-8%

Over the last year, the Operating Expenses growth was -17%. The average annual Operating Expenses growth rates for Hofseth Biocare ASA have been -12% over the past three years , -15% over the past five years , and -8% over the past ten years .

Back to Top